Page last updated: 2024-09-04

beta-lactams and Acinetobacter Infections

beta-lactams has been researched along with Acinetobacter Infections in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (7.58)	18.2507
2000's	23 (34.85)	29.6817
2010's	32 (48.48)	24.3611
2020's	6 (9.09)	2.80

Authors

Authors	Studies
Alquethamy, SF; Bauer, MJ; Beatson, SA; Blaskovich, MAT; Brouwer, S; Cork, AJ; De Oliveira, DMP; El-Deeb, IM; Forde, BM; Harbison-Price, N; Keller, N; Li, G; McDevitt, CA; McEwan, AG; Paterson, DL; Phan, MD; Roberts, JA; Schembri, MA; Steiner, B; von Itzstein, M; Walker, MJ; Zhang, B; Zuegg, J	1
Bassetti, M; Giacobbe, DR; Vena, A	1
Çağlan, E; Gür, D; Nigiz, Ş; Sancak, B	1
Chang, FY; Fung, CP; Lin, JC; Liou, CH; Siu, LK; Tsai, YK	1
Hammer, P; Linde, J; Makarewicz, O; Neubauer, H; Nguyen, NH; Nguyen, TNM; Pletz, MW; Splettstoesser, WD; Sprague, LD; Wareth, G	1
Bassetti, M; Giacobbe, DR; Labate, L; Russo, C; Vena, A	1
Ha, DT; Ho-Le, TP; Hoang, HQ; Nguyen, DA; Nguyen, TA; Nguyen, TSM; Nguyen, TV; Pham, TTN; Tran, GM; Tran, NV; Tran-Nguyen, CH	1
Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C	1
Higgins, PG; Seifert, H; Stefanik, D; Sutcliffe, JA	1
Benmahmod, AB; Ibrahim, RH; Said, HS	1
Chen, Y; Du, X; Fu, Y; Ji, J; Wang, H; Yu, Y	1
Chen, L; Liu, S; Lu, Z; Schwarz, S; Si, W; Wang, XM; Yu, S; Zhang, RM; Zhang, WJ	1
Hall, RM; Hamidian, M	1
Aridogan, BC; Cetin, ES; Ozseven, AG; Tekeli, A; Us, E	1
Dobreva, E; Ivanov, I; Kantardjiev, T; Todorova, B; Velinov, T	1
Kim, HJ; Kim, MJ; Lee, SE; Sohn, JW; Yang, KS; Yoon, YK	1
Bahador, A; Esmaeili, D; Jalalvand, N; Kholdi, S; Nasrolahei, M; Saghi, H; Zahedi, B	1
Castanheira, M; Costello, SE; Davies, TA; Deshpande, LM; Jones, RN; Woosley, LN	1
Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS	1
Barth, AL; Martins, AF; Nordmann, P; Pagano, M; Poirel, L; Rozales, FP; Zavascki, AP	1
Nordmann, P; Poirel, L; Potron, A	1
Córdoba, J; Coronado-Álvarez, NM; Parra, D; Parra-Ruiz, J	1
Hawkey, J; Holt, KE; Hon, PY; Hsu, LY; Koh, TH; Leong, ML; Lim, TP; Ng, MM; Ong, RT; Tan, TY; Teo, JQ	1
Barrios, H; Cevallos, MA; Garza-Ramos, U; Magaña-Aquino, M; Niño-Moreno, P; Reyna-Flores, F; Sánchez-Pérez, A; Silva-Sanchez, J; Tamayo-Legorreta, E; Tovar-Oviedo, J; Turrubiartes-Martínez, E	1
Kwon, DH; Lee, S; Razqan, GS	1
Mitov, I; Ouzounova-Raykova, V; Strateva, T; Todorova, A	1
Antonelli, M; Cambieri, A; Cataldo, MA; Cauda, R; De Pascale, G; Fadda, G; Manno, D; Sanguinetti, M; Spanu, T; Tacconelli, E	1
Amicosante, G; Aschi, M; Celenza, G; Forcella, C; Luzi, C; Pellegrini, C; Perilli, M; Segatore, B; Setacci, D	1
Chuang, LY; Lee, S; Su, PW; Yang, CH; Yang, CS	1
Boo, TW; Crowley, B	1
Ishibashi, Y; Kitamura, J; Sakane, T; Sato, H; Sato, M; Shimada, T; Takahashi, N; Tanabe, K; Yoshitomi, H	1
Dammhayn, C; Hackel, M; Higgins, PG; Seifert, H	1
Lee, HJ; Lee, KM; Suh, JT; Yang, HY	1
Amyes, SG; Evans, BA; Hamouda, A; Towner, KJ	1
Choi, J; Chong, Y; Docquier, JD; Hong, SG; Jeong, SH; Kim, CK; Koh, E; Lee, K; Rossolini, GM; Song, S; Yong, D; Yum, JH	1
Chen, Z; Du, X; Guo, J; Huang, L; Liu, N; Liu, S; Qlu, S; Song, H; Wang, L; Wang, Y; Wang, Z; Yuan, J	1
Chen, CP; Chen, TL; Fung, CP; Huang, LJ; Kuo, SC; Lee, YT; Liang-Yu, C; Liu, CY; Luo, BS	1
Espinal, P; Roca, I; Vila, J	1
Hanifah, YA; Kong, BH; Thong, KL; Yusof, MY	1
Bonnin, RA; Boulanger, A; Kaase, M; Nordmann, P; Poirel, L; Schrenzel, J	1
Chen, L; Deng, Q; Fu, J; Gong, S; Guan, R; Huang, Y; Liao, C; Wang, D; Wang, J; Xia, H; Xie, Y; Yang, Y; Zhou, Z	1
Bogaerts, P; Denis, O; Deplano, A; Glupczynski, Y; Hallin, M; Huang, TD; Rezende de Castro, R; Roisin, S	1
Bonnin, RA; Nordmann, P; Poirel, L	1
Melander, C; Peng, L; Su, R; Su, Z; Yeagley, AA	1
Benoit-Cattin, T; Bonnin, RA; Nordmann, P; Poirel, L	1
Higgins, PG; Seifert, H; Stefanik, D; Wisplinghoff, H	1
Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A	1
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F	1
Bolmström, A; Chong, Y; Karlsson, A; Lee, K; Lim, YS; Qwärnström, A; Yong, D; Yum, JH	1
Burgess, DS; Frei, CR	1
Aggarwal, P; Capoor, MR; Gupta, B; Nair, D; Srivastava, L	1
Rahal, JJ	1
DeRyke, CA; Kuti, JL; Nicolau, DP	1
Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ	1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A	1
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M	1
Allali, S; Kernbaum, S; Naas, T; Nordmann, P	1
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y	1
Ikonomidis, A; Maniatis, AN; Ntokou, E; Pournaras, S; Tsakris, A	1
Benallaoua, S; Brasme, L; De Champs, C; Gharout, A; Madoux, J; Touati, A	1
Epstein, NE; Hollingsworth, R; Silvergleid, RS	1
Bergogne-Bérézin, E; Bourdelier, E; Decré, D; Herrman, JL; Joly-Guillou, ML	1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R	1
Alarcón, T; López, S; López-Brea, M	1
Carbon, C; Farinotti, R; Joly-Guillou, ML; Wolff, M	1
Hájek, V; Hejnar, P; Kolár, M	1

Reviews

5 review(s) available for beta-lactams and Acinetobacter Infections

Article	Year
Management of nonfermenting gram-negative infections: a critique of the guidelines. Current opinion in infectious diseases, 2023, 12-01, Volume: 36, Issue:6 Topics: Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Communicable Diseases; Gram-Negative Bacteria; Humans; Monobactams	2023
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. International journal of antimicrobial agents, 2015, Volume: 45, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections	2015
Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Sep-01, Volume: 43 Suppl 2 Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones	2006
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia. The European respiratory journal, 2007, Volume: 29, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome	2007
[Microbiological and therapeutic considerations of Acinetobacter spp. infection]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Humans	1998

Other Studies

61 other study(ies) available for beta-lactams and Acinetobacter Infections

Article	Year
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 2022, 02-22, Volume: 13, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; COVID-19; Drug Resistance, Multiple, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Pandemics; Pneumonia, Ventilator-Associated; Tetracycline; Tigecycline; Zinc	2022
Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii. Acta microbiologica et immunologica Hungarica, 2020, Jun-01, Volume: 67, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Tetracyclines; Turkey	2020
Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics. International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Discovery; Drug Resistance, Multiple, Bacterial; Genetic Engineering; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Quinolones; Tetracyclines	2020
Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam. International journal of antimicrobial agents, 2020, Volume: 56, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Germany; Humans; Macrolides; Microbial Sensitivity Tests; Milk; Vietnam; Whole Genome Sequencing	2020
Therapeutic options for difficult-to-treat A Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2021
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC infectious diseases, 2017, 06-15, Volume: 17, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Intensive Care Units; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Vietnam	2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nature microbiology, 2017, Jun-30, Volume: 2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam	2017
In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii. International journal of antimicrobial agents, 2018, Volume: 51, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colistin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Tetracyclines	2018
Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World journal of microbiology & biotechnology, 2018, Dec-03, Volume: 34, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; DNA Transposable Elements; Egypt; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing	2018
In vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii. International journal of antimicrobial agents, 2013, Volume: 41, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cefoperazone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins	2013
Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Gene Order; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Swine; Swine Diseases; Synteny	2013
Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Australia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; DNA Transposable Elements; DNA, Bacterial; Gene Duplication; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA	2014
Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods. Japanese journal of infectious diseases, 2013, Volume: 66, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Polymyxin B; Rifampin	2013
First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria. World journal of microbiology & biotechnology, 2014, Volume: 30, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; beta-Lactams; Bulgaria; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction	2014
Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship. PloS one, 2014, Volume: 9, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests	2014
Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran. Annals of clinical microbiology and antimicrobials, 2014, Sep-25, Volume: 13 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction	2014
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-2 Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Europe; Gene Expression; Humans; Integrons; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA	2014
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii. Acta crystallographica. Section D, Biological crystallography, 2014, Volume: 70, Issue:Pt 11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation	2014
Emergence of NDM-1-producing Acinetobacter pittii in Brazil. International journal of antimicrobial agents, 2015, Volume: 45, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Communicable Diseases, Emerging; Genotype; Humans; Male; Microbial Sensitivity Tests; Mutagenesis, Insertional; Polymerase Chain Reaction	2015
In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Colistin; Colony Count, Microbial; Daptomycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Limit of Detection; Microbial Sensitivity Tests; Models, Biological; Models, Statistical	2015
Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Isoenzymes; Microbial Sensitivity Tests; Molecular Sequence Annotation; Mutation; Polymyxin B; Transcription Factors	2015
Outbreak Caused by blaOXA-72-Producing Acinetobacter baumannii ST417 Detected in Clinical and Environmental Isolates. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colistin; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Humans; Isoenzymes; Mexico; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; Tertiary Care Centers; Tigecycline	2016
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Jan-15, Volume: 24 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catechin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts	2017
Emergence of a PER-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii clinical isolate in Bulgaria. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Bulgaria; Drug Resistance, Multiple, Bacterial; Humans; Male	2008
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Catheters, Indwelling; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Staphylococcal Infections	2008
Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Bolivia; Ceftazidime; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutation, Missense; Protein Structure, Tertiary; Substrate Specificity	2008
Genotype and antibiotic susceptibility patterns of drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in Taiwan. Microbial drug resistance (Larchmont, N.Y.), 2008, Volume: 14, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique; Taiwan	2008
Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned? Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 6 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Ireland; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA	2009
A case of unforeseen intractable severe bacteremia due to Acinetobacter baumannii--an efficacy of sulbactam--. Japanese journal of infectious diseases, 2009, Volume: 62, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood; Female; Humans; Middle Aged; Sulbactam; Treatment Outcome	2009
Global spread of carbapenem-resistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Asia; Australia; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Europe; Humans; Latin America; Microbial Sensitivity Tests; Molecular Epidemiology; North America; Polymerase Chain Reaction; Prevalence; South Africa	2010
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests	2009
Novel genetic context of multiple bla OXA-58 genes in Acinetobacter genospecies 3. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:8 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blotting, Southern; DNA Transposable Elements; DNA, Bacterial; DNA, Ribosomal Spacer; Ertapenem; Gene Duplication; Gene Order; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Restriction Mapping; Sequence Analysis, DNA; Thienamycins	2010
Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases. International journal of antimicrobial agents, 2010, Volume: 36, Issue:3 Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Sequence Analysis, DNA	2010
Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Mar-01, Volume: 52, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Humans	2011
Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cluster Analysis; Colistin; Drug Resistance, Bacterial; Enzyme Inhibitors; Genotype; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan	2011
Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future microbiology, 2011, Volume: 6, Issue:5 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Species Specificity	2011
Antimicrobial susceptibility profiling and genomic diversity of multidrug-resistant Acinetobacter baumannii isolates from a teaching hospital in Malaysia. Japanese journal of infectious diseases, 2011, Volume: 64, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Environmental Microbiology; Fomites; Genome, Bacterial; Hand; Hospitals; Humans; Infectious Disease Transmission, Professional-to-Patient; Intensive Care Units; Malaysia; Microbial Sensitivity Tests; Polymyxin B	2011
Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Switzerland	2012
Identification of New Delhi metallo-β-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China. Canadian journal of microbiology, 2012, Volume: 58, Issue:1 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Recombinant Proteins	2012
Emergence of NDM-1-producing Acinetobacter baumannii in Belgium. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Gene Transfer, Horizontal; Humans; Male; Microbial Sensitivity Tests; Plasmids	2012
A novel and hybrid composite transposon at the origin of acquisition of bla(RTG-5) in Acinetobacter baumannii. International journal of antimicrobial agents, 2012, Volume: 40, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA Transposable Elements; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity	2012
Structural studies on 4,5-disubstituted 2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to β-lactams. ChemMedChem, 2012, Volume: 7, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Biofilms; Humans; Imidazoles; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections	2012
Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago. International journal of antimicrobial agents, 2013, Volume: 41, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftazidime; Comoros; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests	2013
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam	2004
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem]. Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins	2004
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin	2004
Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp. Journal of clinical microbiology, 2005, Volume: 43, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Alleles; beta-Lactamases; beta-Lactams; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas putida; Sensitivity and Specificity	2005
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections	2005
Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. The Journal of communicable diseases, 2005, Volume: 37, Issue:2 Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome	2005
Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004. Pharmacotherapy, 2007, Volume: 27, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cross Infection; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests	2007
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA	2007
Multidrug-resistant Acinetobacter baumannii, Russia. Emerging infectious diseases, 2007, Volume: 13, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; France; Humans; Male; Microbial Sensitivity Tests; Patient Transfer; Russia	2007
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA	2007
Hidden VIM-1 metallo-beta-lactamase phenotypes among Acinetobacter baumannii clinical isolates. Journal of clinical microbiology, 2008, Volume: 46, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction	2008
First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagnostic microbiology and infectious disease, 2008, Volume: 60, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Fluoroquinolones; Hospitals; Humans; Polymerase Chain Reaction; Sequence Analysis, DNA	2008
Increased postoperative cervical myelopathy and cord compression resulting from the use of Gelfoam. The spine journal : official journal of the North American Spine Society, 2009, Volume: 9, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Cervical Vertebrae; Decompression, Surgical; Ertapenem; Female; Gelatin Sponge, Absorbable; Hemostatics; Humans; Laminectomy; Magnetic Resonance Imaging; Postoperative Complications; Spinal Cord Compression	2009
Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Phenotype	1995
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic	1997
In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6 Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enzyme Inhibitors; Female; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin	1999
Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc. Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 1999, Volume: 142 Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Czech Republic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Phenotype	1999